This observation in patients with SSc-ILD contrasted with the utility of serial KL-6 level measurements in patients with ILD associated with myositis or anti-synthetase syndrome, in which serial changes in KL-6 levels were useful to predict treatment response, long-term outcomes and relapse [31,32,33,34,35]. Here, MUC1 is linked to interstitial lung disease.